Edition:
India

Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

109.30USD
26 Apr 2017
Change (% chg)

-- (--)
Prev Close
$109.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
517,123
52-wk High
$121.75
52-wk Low
$81.13

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan... (more)

Overall

Beta: 0.67
Market Cap(Mil.): $23,082.63
Shares Outstanding(Mil.): 211.19
Dividend: --
Yield (%): --

Financials

BRIEF-Edwards Lifesciences Q1 earnings per share $1.06

* Says Q1 earnings per share $1.06; Q1 adjusted earnings per share $0.94; Q1 sales grew 27 percent to $884 million

26 Apr 2017

Edwards profit tops expectations on soaring heart valve sales

April 25 Edwards Lifesciences Corp on Tuesday reported higher-than expected first-quarter profit and revenue on surging sales of transcatheter heart valve replacements, and raised its full-year earnings forecast to reflect the strong start to the year.

26 Apr 2017

BRIEF-German patent court issues initial decision

* District court in Germany ruled that Boston Scientific's lotus valve infringes one of co's patents for transcatheter aortic valves

09 Mar 2017

BRIEF-Boston Scientific receives favorable rulings in Edwards Lifesciences litigation

* Boston scientific receives favorable rulings in edwards lifesciences litigation

09 Mar 2017

Edwards Lifesciences 4th-quarter sales, profit top expectations

Feb 1 Edwards Lifesciences Corp on Wednesday reported higher-than-expected fourth-quarter profit and revenue on surging demand for its minimally invasive heart valve replacement systems.

02 Feb 2017

BRIEF-Edwards Lifesciences Corp Q4 EPS $0.73

* Q4 global transcatheter heart valve therapy sales up 29 percent to $432 million

02 Feb 2017

Edwards Lifesciences to buy Israel's Valtech for up to $690 million

JERUSALEM Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

28 Nov 2016

UPDATE 1-Edwards Lifesciences to buy Israel's Valtech for up to $690 mln

JERUSALEM, Nov 28 Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

28 Nov 2016

Edwards Lifesciences to buy Israel's Valtech for up to $690 mln

JERUSALEM, Nov 28 Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

28 Nov 2016

BRIEF-Edwards enters into agreement to acquire Valtech Cardio

* Purchase price of Valtech is $340 million in stock and cash at closing,

28 Nov 2016

More From Around the Web

Earnings vs. Estimates